Prosecution Insights
Last updated: November 04, 2026

Dynamic42 GmbH

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials

2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready

Analysis

Dynamic42 GmbH currently faces 2 pending office actions in the Chemistry & Materials technology area. The portfolio involves 2 distinct examiners and a matching number of distinct art units, suggesting that the workload is split between different review groups. This structure indicates that the company's technical developments are being assessed from multiple perspectives within the patent office.

ABEL, LENORA A is the busiest examiner, holding 1 pending office action. This indicates that the pending office actions are shared among the distinct examiners assigned to the company's matters. For the practitioner, this decentralized approach means that the outcomes of the prosecution are not tied to a single individual. The use of multiple art units for these filings suggests a breadth of technical subject matter that requires specialized expertise across different examination divisions.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
2
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)2 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HASSAN, LIBAN M 1 51.1% +30.4%
ABEL, LENORA A 1 68.9% +33.4%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18469397 CELL CULTURE CHAMBER AND METHOD FOR CULTURING CELLS AND FOR THE IN VITRO PRODUCTION OF CELL LAYERS AND ORGAN MODELS HASSAN, LIBAN M —
18469439 BASE ELEMENT OF A MULTI-CHAMBER BIOCHIP, PRODUCTION OF THE MULTI-CHAMBER BIOCHIP, AND USE THEREOF FOR ESTABLISHING ORGAN AND DISEASE MODELS AND SUBSTANCE TESTS ABEL, LENORA A —

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18469397 CELL CULTURE CHAMBER AND METHOD FOR CULTURING CELLS AND FOR THE IN VITRO PRODUCTION OF CELL LAYERS AND ORGAN MODELS HASSAN, LIBAN M —
18469439 BASE ELEMENT OF A MULTI-CHAMBER BIOCHIP, PRODUCTION OF THE MULTI-CHAMBER BIOCHIP, AND USE THEREOF FOR ESTABLISHING ORGAN AND DISEASE MODELS AND SUBSTANCE TESTS ABEL, LENORA A —

Top Art Units

Art UnitApps
1653 1
1799 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18469397 CELL CULTURE CHAMBER AND METHOD FOR CULTURING CELLS AND FOR THE IN VITRO PRODUCTION OF CELL LAYERS AND ORGAN MODELS HASSAN, LIBAN M 1653 §103§112 Non-Final OA — Pending Sep 18, 2023
18469439 BASE ELEMENT OF A MULTI-CHAMBER BIOCHIP, PRODUCTION OF THE MULTI-CHAMBER BIOCHIP, AND USE THEREOF FOR ESTABLISHING ORGAN AND DISEASE MODELS AND SUBSTANCE TESTS ABEL, LENORA A 1799 §102§112 Non-Final OA — Pending Sep 18, 2023

Managing Dynamic42 GmbH's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Dynamic42 GmbH have?

Dynamic42 GmbH has 2 pending office actions as of November 2026, spread across 2 art units and 2 examiners.

Which USPTO examiner handles the most Dynamic42 GmbH applications?

Liban M Hassan has the most, with 1 of Dynamic42 GmbH's pending office actions.

What technology area are Dynamic42 GmbH's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month